CME

CME


Future Directions: Targeting LAG-3 in Melanoma Treatment

April 26, 2024

Host: Hussein Tawbi, MD, PhD


This activity focuses on improving clinician awareness and knowledge of LAG-3-based immunotherapy in metastatic melanoma. We aim to identify patients with metastatic melanoma who can benefit from LAG-3/PD-1 combinati